Introduction
In recent years, healthcare expenditure has come under increasing scrutiny in France and progressively restrictive budgetary measures have been implemented in order to contain growing spending. In this context, health economic assessment has gained a more central role for both public and industry interests as a means to support Market Access negotiations and to best guide resource allocation choices.
Beginning in 2013, submission of a costeffectiveness/utility analysis to the CEESP (Health Economic and Public Health Evaluation Commission) has become mandatory for healthcare products for which a high level of added medical benefit, which is linked to obtaining a higher price, is sought and which are likely to have a significant impact on the healthcare system and expenditure 1 .
While the French National Authority for Health (HAS) has published guidelines 2 for conducting health economic analyses, there is a need to harmonize current practice in terms of which sources are used for costing in France, especially to increase comparability between each assessment. Currently, a wide array of sources and methods are employed in evaluating the costs of physician visits and technical procedures, for example.
In the interest of increasing transparency and access to healthcare utilization data, the French government has published the highly anticipated Open DAMIR database as part of a broader move towards sharing open data 3 .
The DAMIR (French National Health Insurance CrossScheme Expenditure) database consists of monthly extractions of aggregated data from the larger French national health insurance database 4 (SNIIR-AM; French National Health Insurance Information System). The exhaustive SNIIR-AM database is not currently directly accessible to the public or industry.
Conclusions
This study confirms that Open DAMIR data can provide a more nuanced estimation of the cost of certain care services than is commonly used for health economic evaluation in France. Open DAMIR data could prove to be an easily accessible and useful tool in assessing real-life healthcare resource use and costs. In addition, the ability to evaluate data from the national, regional (9 regions), and local levels (101 departments) enables precise analysis when geographical considerations are relevant to the economic assessment.
However, major limitations for broader health economic analyses include the inability to link patient-level data for longitudinal analysis and outcomes, the lack of information on patient diagnosis and pharmacologic treatment, and the large definitions for technical procedures (rendering analysis of specific procedures difficult).
In conclusion, while the publication of this database represents a step forward in the age of open data, the inclusion of select additional variables to the database would further increase its usefulness in health economic assessment.
The objective of this study was to perform an exploratory analysis of the DAMIR database in order to estimate the real-world mean cost of each type of physician visit and the mean surcharge rate for technical procedures, by specialty, in order to better inform health economic modeling of French healthcare resource consumption. A secondary objective was to conduct a regional analysis of specialist physician visit costs to assess disparities in costs between regions in France.
Data source:
Like the SNIIR-AM database from which its aggregated data are extracted, the DAMIR database covers all health insurance beneficiaries, including all schemes, thereby encompassing the entire French population. The database contains anonymized information for all types of care which are billed to the National Health Insurance schemes for reimbursement, in both the inpatient and outpatient settings.
Study design:
We analyzed data collected over a 3-month period (September-November 2014), including outpatient physician visits and technical procedures. For all analyses, total costs were estimated from the collective (all-payer) perspective, in accordance with French guidelines on health economic assessment 2 .
National level analysis of cost per physician visit:
We calculated mean costs for each type of visit, including surcharges. This equates to the total sum billed for reimbursement including the legally defined fee for a visit, which varies by specialty, plus the surcharge (billing above the legally defined fee for a visit). Most general practitioners and certain specialist physicians have a contractual obligation not to bill above their basic fee, but other specialists are free to include a surcharge. Outpatient physician visits, including community or hospital-based practices, coded as general practice and for all types of specialties were included.
National level analysis of technical procedure surcharges:
We calculated the mean surcharge rate for technical procedures for each specialty. All types of technical
Objectives

Methods
Results
The 3 monthly DAMIR extractions analyzed included a total of 98,684,544 outpatient physician visits (including 18,950,388 specialist visits) and 54,310,532 technical procedures.
National level analysis of cost per physician visit:
The three types of visits associated with the highest mean costs were for neurologists (€50.58 per visit), surgeons (€45.74), and psychiatrists (€43.96), whereas the lowest mean costs were for general practitioners (€24.13), nephrologists (€25,58), and geriatricians (€29.58). Mean costs per visit, for all specialties, are presented in Table 1 .
National level analysis of technical procedure surcharges:
The highest surcharge rates for technical procedures were billed by surgeons (mean surcharge of +55.6% of the minimum reimbursable fee for a given procedure) and stomatologists (+50.6%), while the lowest rates of surcharges were billed by nephrologists (<+1.0%) and pulmonologists (+3.2%). Mean surcharge rates for technical procedures for all specialties are presented in Table 1 .
Regional analysis of cost per specialist visit (general medicine excluded):
The regional analysis revealed geographic disparities in the mean cost of a specialist visit, depending on region ( Figure  1 ). As expected, the mean cost for specialist visits was highest in the greater Paris metropolitan area (mean of €43.58, all specialties included), with other regions trailing further behind (range: €27.92-€33.07). Table 1 1. Decree no. 2012-1116, October 2 nd , 2012 concerning the health economic missions of the French National Authority for Health (HAS). Figure 1 procedures (e.g. diagnostic, surgical, emergency care…) performed by general practitioners or specialists were included in the analysis (including both outpatient and inpatient procedures, except for procedures directly billed as part of a Diagnosis-Related Group). Due to the aggregated coding for technical procedures in the DAMIR database, the mean surcharge rate is calculated on the basis of all procedures performed by each type of physician.
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Coding for a physician visit and for a procedure performed by a physician are mutually exclusive: when a procedure is performed during a physician visit, the physician is reimbursed based on the legally defined fee for the procedure and not on the fee for the visit, aside from certain minor exceptions (e.g. ECG for cardiologist visits) which are billed on top of a visit.
Regional analysis of cost per specialist visit:
We also conducted a regional analysis of specialist physician visits by calculating the overall mean cost for specialist visits in each of the 9 major geographical regions by which DAMIR data are coded. General practitioner visits were excluded from the regional analysis due to having a largely uniform set fee nationwide (€ 23). 
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